SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-19-000035
Filing Date
2019-05-09
Accepted
2019-05-09 16:27:59
Documents
83
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20190331x10q.htm 10-Q 1344142
2 EX-10.1 kdmn-20190331xex10_1.htm EX-10.1 78406
3 EX-31.1 kdmn-20190331xex31_1.htm EX-31.1 19981
4 EX-31.2 kdmn-20190331xex31_2.htm EX-31.2 20022
5 EX-32.1 kdmn-20190331xex32_1.htm EX-32.1 10265
6 EX-32.2 kdmn-20190331xex32_2.htm EX-32.2 10103
  Complete submission text file 0001557142-19-000035.txt   6419245

Data Files

Seq Description Document Type Size
7 EX-101.INS kdmn-20190331.xml EX-101.INS 1229546
8 EX-101.SCH kdmn-20190331.xsd EX-101.SCH 53415
9 EX-101.CAL kdmn-20190331_cal.xml EX-101.CAL 69480
10 EX-101.DEF kdmn-20190331_def.xml EX-101.DEF 240385
11 EX-101.LAB kdmn-20190331_lab.xml EX-101.LAB 435761
12 EX-101.PRE kdmn-20190331_pre.xml EX-101.PRE 403264
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 19810972
SIC: 2834 Pharmaceutical Preparations